Cargando…
Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme
The invasiveness and high immune suppression of glioblastoma multiforme (GBM) produce poor survival of afflicted patients. Unfortunately, in the past decades, no therapeutic approach has remarkably improved the survival time of patients with GBM. Our analysis of the TCGA database and brain tumor tis...
Autores principales: | Hu, Jiemiao, Zhao, Qingnan, Kong, Ling-Yuan, Wang, Jian, Yan, Jun, Xia, Xueqing, Jia, Zhiliang, Heimberger, Amy B., Li, Shulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840139/ https://www.ncbi.nlm.nih.gov/pubmed/33571109 http://dx.doi.org/10.1126/sciadv.abc2511 |
Ejemplares similares
-
FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells
por: Zhao, Qingnan, et al.
Publicado: (2023) -
MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme
por: Marisetty, Anantha, et al.
Publicado: (2020) -
A microfluidics-based method for isolation and visualization of cells based on receptor-ligand interactions
por: Dao, Long, et al.
Publicado: (2022) -
Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018) -
Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile
por: Zhao, Qingnan, et al.
Publicado: (2019)